Shopping Cart 0
Cart Subtotal
USD 0

Mauna Kea Technologies SAS (MKEA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT's cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT's products are used for treatment of digestive diseases and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS (MKEA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11

Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12

Debt Offering 13

Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13

Mauna Kea Technologies SAS-Key Competitors 14

Mauna Kea Technologies SAS-Key Employees 15

Mauna Kea Technologies SAS-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Financial Announcements 17

Sep 20, 2018: Mauna Kea Technologies reports first half 2018 financial results 17

Sep 20, 2017: Mauna Kea Technologies Reports First Half 2017 Financial Results 19

Jul 25, 2017: Mauna Kea Technologies Reports First Half 2017 Sales 21

Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 22

Mar 23, 2017: Mauna Kea Technologies Reports Full Year 2016 Financial Results And Highlights 2017 Key Priorities 23

Jan 24, 2017: Mauna Kea Technologies Reports Fourth Quarter and Full Year 2016 Sales 25

Corporate Communications 26

Apr 05, 2018: Appointment of Christophe Lamboeuf to the position of Chief Financial Officer 26

Jan 15, 2018: Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O'Neill, to Board of Directors 27

Oct 17, 2017: Mauna Kea Technologies Appoints Olivier Regnard as Deputy CEO And Chief Financial Officer 28

Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 29

Other Significant Developments 30

Jul 25, 2018: Mauna Kea Technologies Reports Second Quarter and First Half 2018 Sales 30

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11

Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12

Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13

Mauna Kea Technologies SAS, Key Competitors 14

Mauna Kea Technologies SAS, Key Employees 15

Mauna Kea Technologies SAS, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Mauna Kea Technologies SAS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Mauna Kea Technologies SAS (MKT) is an endomicroscopy device manufacturer. The company develops, manufactures and distributes tools to visualize and detect cellular abnormalities during endoscopic procedures. It provides confocal laser endomicroscopy platform. MKT's cellvizio is an endomicroscopy platform that provides microscopic images of tissue instantaneously and in a minimally-invasive way. The company also offers vasculature and vasodynamics studies, longitudinal monitoring of disease progression and in vivo histology. It provides technical support and training. MKT's products are used for treatment of digestive diseases and diagnosing respiratory diseases and also used in laboratories for research on small animals. The company has presence in North America, Europe and Asia. MKT is headquartered in Paris, France.

Mauna Kea Technologies SAS (MKEA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deal Details 11

Equity Offering 11

Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11

Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12

Debt Offering 13

Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13

Mauna Kea Technologies SAS-Key Competitors 14

Mauna Kea Technologies SAS-Key Employees 15

Mauna Kea Technologies SAS-Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Financial Announcements 17

Sep 20, 2018: Mauna Kea Technologies reports first half 2018 financial results 17

Sep 20, 2017: Mauna Kea Technologies Reports First Half 2017 Financial Results 19

Jul 25, 2017: Mauna Kea Technologies Reports First Half 2017 Sales 21

Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 22

Mar 23, 2017: Mauna Kea Technologies Reports Full Year 2016 Financial Results And Highlights 2017 Key Priorities 23

Jan 24, 2017: Mauna Kea Technologies Reports Fourth Quarter and Full Year 2016 Sales 25

Corporate Communications 26

Apr 05, 2018: Appointment of Christophe Lamboeuf to the position of Chief Financial Officer 26

Jan 15, 2018: Mauna Kea Technologies Appoints Experienced Healthcare Executive, Molly O'Neill, to Board of Directors 27

Oct 17, 2017: Mauna Kea Technologies Appoints Olivier Regnard as Deputy CEO And Chief Financial Officer 28

Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 29

Other Significant Developments 30

Jul 25, 2018: Mauna Kea Technologies Reports Second Quarter and First Half 2018 Sales 30

Appendix 32

Methodology 32

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Mauna Kea Technologies SAS, Deals By Therapy Area, 2012 to YTD 2018 8

Mauna Kea Technologies SAS, Medical Devices Deals, 2012 to YTD 2018 9

Mauna Kea Technologies SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Mauna Kea Technologies to Raise USD9.1 Million in Public Offering of Shares 11

Mauna Kea Technologies to Raise USD5.7 Million in Public Offering of Shares 12

Mauna Kea Tech Raises USD4.3 Million in First Tranche of Private Placement of Bonds Due 2022 13

Mauna Kea Technologies SAS, Key Competitors 14

Mauna Kea Technologies SAS, Key Employees 15

Mauna Kea Technologies SAS, Subsidiaries 16

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Mauna Kea Technologies SAS, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.